Oren Gilad
President, CEO at Aprea Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Aprea Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Aprea Therapeutics Inc. June 5, 202596.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Aprea Therapeutics Inc. | Grant or award | +20,175 | — | — |
| Jan 30, 2026 | Aprea Therapeutics Inc. | Open-market purchase | +28,100 | $0.89 | $25,009 |
| Apr 3, 2025 | Aprea Therapeutics Inc. | Open-market purchase | +3,003 | $1.87 | $5,616 |
| Apr 3, 2025 | Aprea Therapeutics Inc. | Open-market purchase | +2,497 | $1.80 | $4,495 |
| Mar 27, 2025 | Aprea Therapeutics Inc. | Grant or award | +6,725 | — | — |
| Oct 23, 2024 | Aprea Therapeutics Inc. | Open-market purchase | +500 | $3.92 | $1,960 |
| Oct 15, 2024 | Aprea Therapeutics Inc. | Open-market purchase | +250 | $2.90 | $725 |
| Oct 14, 2024 | Aprea Therapeutics Inc. | Open-market purchase | +1,000 | $2.59 | $2,590 |
| Oct 10, 2024 | Aprea Therapeutics Inc. | Open-market purchase | +150 | $2.54 | $381 |
| Mar 28, 2024 | Aprea Therapeutics Inc. | Grant or award | +6,725 | — | — |
| Mar 13, 2024 | Aprea Therapeutics Inc. | Open-market purchase | +2,000 | $7.29 | $14,580 |
| Mar 9, 2023 | Aprea Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Aug 23, 2022 | Aprea Therapeutics Inc. | Derivative conversion | +6,045,100 | — | — |
Questions about Oren Gilad
What boards is Oren Gilad on?
Oren Gilad sits on the board of Aprea Therapeutics Inc.
What company is Oren Gilad the CEO of?
Oren Gilad is President, CEO of Aprea Therapeutics Inc.
How long has Oren Gilad served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.